Synergistic Action of Heat-Shock Protein-90 Inhibitor NVP-AUY922 with Histone Deacetylase Inhibition

被引：0
|
作者：
Kaiser, M. [1 ]
Lamottke, B. [1 ]
Jensen, M. R. [2 ]
Quadt, C. [3 ]
Garcia-Echeverria, C. [3 ]
Mieth, M. [1 ]
Heider, U. [1 ]
Sezer, O. [1 ]
机构：
[1] Charite Univ Med Berlin, D-13353 Berlin, Germany
[2] Novartis Inst BioMed Res, Basel, Switzerland
[3] Novartis Pharma AG, Early Clin Dev, Basel, Switzerland
来源：
CLINICAL LYMPHOMA & MYELOMA | 2009年 / 9卷
关键词：
D O I：
10.1016/S1557-9190(11)70721-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [21] Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins
    Lee, Kyung-Hun
    Lee, Ju-Hee
    Han, Sae-Won
    Im, Seock-Ah
    Kim, Tae-You
    Oh, Do-Youn
    Bang, Yung-Jue
    CANCER SCIENCE, 2011, 102 (07) : 1388 - 1395
  • [22] Mechanistic Evaluation of the Novel HSP90 Inhibitor NVP-AUY922 in Adult and Pediatric Glioblastoma
    Gaspar, Nathalie
    Sharp, Swee Y.
    Eccles, Suzanne A.
    Gowan, Sharon
    Popov, Sergey
    Jones, Chris
    Pearson, Andrew
    Vassal, Gilles
    Workman, Paul
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (05) : 1219 - 1233
  • [23] Exploring the inhibitory mechanism of resorcinylic isoxazole amine NVP-AUY922 towards the discovery of potential heat shock protein 90 (Hsp90) inhibitors
    Magwenyane, Ayanda M.
    Lawal, Monsurat M.
    Amoako, Daniel G.
    Somboro, Anou M.
    Agoni, Clement
    Khan, Rene B.
    Mhlongo, NdumisoN.
    Kumalo, Hezekiel M.
    SCIENTIFIC AFRICAN, 2022, 15
  • [24] Phase 1/1B trial of the heat shock protein 90 inhibitor NVP-AUY922 as monotherapy or in combination with bortezomib in patients with relapsed or refractory multiple myeloma
    Seggewiss-Bernhardt, Ruth
    Bargou, Ralf C.
    Goh, Yeow Tee
    Stewart, A. Keith
    Spencer, Andrew
    Alegre, Adrian
    Blade, Joan
    Ottmann, Oliver G.
    Fernandez-Ibarra, Cristina
    Lu, Hong
    Pain, Scott
    Akimov, Mikhail
    Iyer, Swaminathan Padmanabhan
    CANCER, 2015, 121 (13) : 2185 - 2192
  • [25] Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype
    Best, O. Giles
    Mulligan, Stephen P.
    LEUKEMIA & LYMPHOMA, 2012, 53 (11) : 2314 - 2320
  • [26] Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma
    T Stühmer
    A Zöllinger
    D Siegmund
    M Chatterjee
    E Grella
    S Knop
    M Kortüm
    C Unzicker
    M R Jensen
    C Quadt
    P Chène
    J Schoepfer
    C García-Echeverría
    H Einsele
    H Wajant
    R C Bargou
    Leukemia, 2008, 22 : 1604 - 1612
  • [27] NVP-AUY922:: A novel small molecule HSP90 inhibitor with potent in vivo antitumor efficacy
    Jensen, Michael Rugaard
    Schoepfer, Joseph
    Radimersky, Thomas
    Massey, Andrew
    Brueggen, Josef
    Schweitzer, Alain
    Pfaar, Ulrike
    Ruetz, Stephan
    Guy, Chantal
    Buckler, Alan
    Schnell, Christian
    Cozens, Robert
    Brough, Paul
    Drysdale, Martin
    Quadt, Cornelia
    Garcia-Echeverria, Carlos
    Chene, Patrick
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3521S - 3521S
  • [28] Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma
    Stuehmer, T.
    Zoellinger, A.
    Siegmund, D.
    Chatterjee, M.
    Grella, E.
    Knop, S.
    Kortuem, M.
    Unzicker, C.
    Jensen, M. R.
    Quadt, C.
    Chene, P.
    Schoepfer, J.
    Garcia-Echeverria, C.
    Einsele, H.
    Wajant, H.
    Bargou, R. C.
    LEUKEMIA, 2008, 22 (08) : 1604 - 1612
  • [29] NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo
    Lian, Jianpo
    Lin, Dengqiang
    Xie, Xing
    Xu, Yunze
    Xu, Lieyu
    Meng, Li
    Zhu, Yu
    ONCOTARGETS AND THERAPY, 2017, 10 : 2219 - 2226
  • [30] Targeting HSP90 by the Novel Inhibitor NVP-AUY922 Reduces Growth and Angiogenesis of Pancreatic Cancer
    Moser, Christian
    Lang, Sven A.
    Hackl, Christina
    Wagner, Christine
    Scheiffert, Eva
    Schlitt, Hans J.
    Geissler, Edward K.
    Stoeltzing, Oliver
    ANTICANCER RESEARCH, 2012, 32 (07) : 2551 - 2561
12345